Balantidiasis
Treatment Market: Introduction
·
Balantidiasis, also known as Balantidium
coli infection, is a disorder caused by Balantidium coli, an intestinal
protozoan parasite. The parasite is transmitted through the fecal-oral route.
Humans can be infected by the parasite by ingesting infective cysts from food
and water contaminated with defecation. This infection predominantly affects the
large intestine. Diarrhea, weight loss, dysentery, stomach pain, and vomiting
are common side-effects of balantidiasis. The infection is observed to be
prevalent in rural areas in industrially advanced and developing regions due to
water pollution caused by fecal matter of humans and/or pigs. Provision of safe
and clean drinking water can prevent the infection from spreading from one
person to the other. Anti-infective agents are utilized to treat
balantidiasis.
Read Report
Overview: https://www.transparencymarketresearch.com/balantidiasis-treatment-market.html
·
Most of the people suffering from
Balantidiasis are asymptomatic. Some people may become acutely ill with
abnormally high temperatures, vomiting, nausea, abdominal pain, and bloody
diarrhea. Such conditions could result in excessive loss of water from the body
and extreme exhaustion, especially if B. coli attacks the intestinal lining
causing inflammation and possibly ‘crater-like’ areas of damage. In serious
cases, the ulcers could be deep enough to puncture the intestinal wall,
resulting into the acute inflammation of the peritoneum?the membrane that lines
the abdomen (peritonitis). Occasionally, the ulcer may diminish lung function.
·
Tetracycline, a common antibiotic drug, is
commonly prescribed in the treatment of Balantidiasis. When tetracycline cannot
be administered, replacement drug therapy may include iodoquinol or
metronidazole. It is not necessary to isolate the person suffering from
Balantidiasis. However, the feces of infected individuals must be disposed of
so that they don’t came into contact with drinking water or with food supplies.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56175
Key
Drivers, Restraints, and Opportunities of Global Balantidiasis Treatment Market
·
Rise in prevalence of balantidiasis
infection, surge in the trend of swine farming, increase in research &
development activities for the diagnosis of the disease, and surge in awareness
about the treatment options are major factors that are projected to propel the
balantidiasis diagnosis and treatment market during the forecast period. A
study conducted by the Stanford University revealed that incidence of the
infection has been reported in Bolivia, Papua New Guinea, and the Philippines.
The prevalence rate of balantidiasis infection is lower than 1%. Lower
incidence rate in major pharmaceutical markets such as North America and Europe
and competition between already established players are likely to restrain the
global balantidiasis diagnosis and treatment market, in terms of revenue, during
the forecast period.
·
Additionally, a lack of hygiene and
sanitation in rural areas of developing countries is a significant factor that
affects the spread of this disease. Furthermore, increasing awareness regarding
the diseases transmitted via faecal-oral route further boosts the market.
However, competition among existing market players hampers the entry of new
players.
Request for
Analysis of COVID19 Impact on Balantidiasis
Treatment Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56175
Asia
Pacific to Capture Major Share of Global Balantidiasis Treatment Market
Based on
region, the global balantidiasis treatment market can be classified into North
America (the U.S. and Canada), Europe (including Germany, France, and the
U.K.), Asia Pacific (including Australia, China, Japan, and India), Latin
America (including Brazil and Mexico), and Middle East & Africa (including
GCC countries and South Africa). The disease is less prevalent in North
America due to high sanitation standards and quality of living and hygienic
environment. However, the disease is more prevalent in Latin America.
Additionally, prevalence of the disease is low in Europe due to high hygiene
standards, stringent quality control guidelines, hygienic food and water
standards, and government support to maintain good hygiene. Asia Pacific and
Latin America are emerging regions for the market; therefore, the market in
these regions is projected to expand at a significant pace during the forecast
period.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=56175
Rapid
expansion of the balantidiasis treatment market in these regions can be
attributed to the increase in incidence of this infection, poor hygiene
conditions, expansion of the healthcare industry, and rise in government
investment to develop healthcare infrastructure in these regions. The
balantidiasis treatment market in countries such as China, India, and Brazil is
projected to expand at a high growth rate during the forecast period due to an
increase in awareness among the population about protozoal infections and their
treatments. Furthermore, the burden of gastrointestinal diseases is rising due
to the increase in the number of pylori infection cases and changes in
lifestyle such as consumption of alcohol, smoking, and sedentary work profile.
Pre-Book Balantidiasis Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=56175<ype=S
Key
Players Operating in Global Balantidiasis Treatment Market
The global
balantidiasis treatment market is highly fragmented, with the presence of
various key players. A large number of manufacturers hold a major share
in their respective regions.
More Trending
Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/inoculation-drives-to-attract-considerable-growth-for-the-disposable-syringes-market-auto-disposable-syringes-to-paint-bold-strokes-of-growth-tmr-301325488.html
https://www.prnewswire.com/news-releases/valuation-in-geriatric-medicines-market-to-reach-us-1142-8-bn-by-2027--use-in-managing-cardiovascular-diseases-spurs-growth-tmr-301331572.html
https://www.prnewswire.com/news-releases/asia-pacific-to-emerge-as-a-champion-growth-generating-region-for-the-antibacterial-drugs-market-due-to-escalating-government-initiatives-and-increasing-patient-population-tmr-insights-301333796.html
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of Analysts, Researchers, and Consultants, use proprietary data sources and
various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
